𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuropsychological effects of interferon β-1a in relapsing multiple sclerosis

✍ Scribed by Jill S. Fischer; Roger L. Priore; Lawrence D. Jacobs; Diane L. Cookfair; Richard A. Rudick; Robert M. Herndon; John R. Richert; Andres M. Salazar; Donald E. Goodkin; Carl V. Granger; Jack H. Simon; Jordan H. Grafman; Muriel D. Lezak; Kathleen M. O'Reilly Hovey; Katherine Kawczak Perkins; Danielle Barilla-Clark; Mark Schacter; David W. Shucard; Anna L. Davidson; Karl E. Wende; Dennis N. Bourdette; Mariska F. Kooijmans-Coutinho

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
173 KB
Volume
48
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Real-life impact of early interferonβ th
Real-life impact of early interferonβ therapy in relapsing multiple sclerosis
✍ M. Trojano; F. Pellegrini; D. Paolicelli; A. Fuiani; G.B. Zimatore; C. Tortorell 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

## Abstract ## Objective Recent findings support greater efficacy of early vs. delayed interferon beta (IFNβ) treatment in patients with a first clinical event suggestive of multiple sclerosis (MS). We aimed to evaluate the effectiveness of early IFNβ treatment in definite relapsing‐remitting MS (

Identify of interferon-β1a product in mu
Identify of interferon-β1a product in multiple sclerosis study
✍ Wieland W. Wolf 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

We extend sincere congratulations to Dr Jacobs and colleagues for the successful conclusion of their study of recombinant interferon p l a (rIFN-pla) in patients with multiple sclerosis (MS). The impressive results showed that 6 million international units of rIFN-Pla applied once weekly via the int